BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 6764113)

  • 1. [Clinical evaluation of antiemetics for vomiting due to cancer chemotherapy in children].
    Ise T; Ohira M; Omiya A; Hirose M; Shibata T
    Gan To Kagaku Ryoho; 1982 Jul; 9(6):1108-18. PubMed ID: 6764113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The control of chemotherapy-induced nausea and vomiting].
    Shinkai T; Saijo N; Sawamura N; Funaki U; Takahashi S; Yokoyama S; Fujita J; Futami H; Sasaki Y; Shimizu E
    Gan No Rinsho; 1985 Jun; 31(7):779-91. PubMed ID: 3897622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A survey of antiemetic use in children with cancer.
    van Hoff J; Hockenberry-Eaton MJ; Patterson K; Hutter JJ
    Am J Dis Child; 1991 Jul; 145(7):773-8. PubMed ID: 2058609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative trial between two drugs in the treatment of vomiting induced by anti-cancer chemotherapy (author's transl)].
    Zylberait D; Krulik M; Audebert AA; Debray J
    Sem Hop; 1981 Jan 8-15; 57(1-2):47-9. PubMed ID: 6258237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind comparison of domperidone and metoclopramide suppositories in the treatment of nausea and vomiting in children.
    Van Eygen M; Dhondt F; Heck E; Ameryckx L; Van Ravensteyn H
    Postgrad Med J; 1979; 55 Suppl 1():36-9. PubMed ID: 382153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperative vomiting treated with domperidone. A double-blind comparison with metoclopramide and a placebo.
    Boghaert A; Carron D; Gallant J; Stockman A
    Acta Anaesthesiol Belg; 1980; 31(2):129-37. PubMed ID: 7008487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prophylactic antiemetic treatment for cancer chemotherapy--comparison of domperidone and chlorpromazine].
    Araki Y; Tamura K; Seita M
    Gan To Kagaku Ryoho; 1983 Nov; 10(11):2335-40. PubMed ID: 6639095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Domperidone drops in the symptomatic treatment of chronic paediatric vomiting and regurgitation. A comparison with metoclopramide.
    De Loore I; Van Ravensteyn H; Ameryckx L
    Postgrad Med J; 1979; 55 Suppl 1():40-2. PubMed ID: 382154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
    Sorbe BG
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A report comparing the use of tropisetron (Navoban), a 5-HT3 antagonist, with a standard antiemetic regimen of dexamethasone and metoclopramide in cisplatin-treated patients under conditions of severe emesis.
    Madej G; Krzakowski M; Pawinski A; Lasota W; Rogowski W; Skoneczna I
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):3-6. PubMed ID: 9113119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical evaluation of granisetron (BRL43694) in nausea and vomiting induced by anticancer drugs--pediatrics].
    Sawada T; Matsumura T; Mugishima H; Kaneko M; Ohira M; Sugimoto T; Onuma N; Sakurai M; Takeda T
    Gan To Kagaku Ryoho; 1999 Aug; 26(9):1295-304. PubMed ID: 10478183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Assessment of the efficacy of drugs used in prevention of vomiting during anticancer therapy in children].
    Gadomski A; Zmudzka I; Wójtowicz H
    Pol Tyg Lek; 1990 May 21-28; 45(21-22):422-4. PubMed ID: 2267193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of emesis by tropisetron (Navoban) in children receiving cytotoxic therapy for solid malignancies.
    Otten J; Hachimi-Idrissi S; Balduck N; Maurus R
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):17-9. PubMed ID: 9113122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Palliative therapy in cancer. 5. Side effects by anticancer drugs and their treatments].
    Urushizaki I
    Gan To Kagaku Ryoho; 1990 Sep; 17(9):1959-69. PubMed ID: 1697455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The antiemetic effect and clinical evaluation of metoclopramide alone and combined with betamethasone in children with malignant tumor].
    Hatae Y; Takeda T; Nakadate H; Hatayama Y; Kishino T; Ogawa Y
    Gan To Kagaku Ryoho; 1989 Nov; 16(11):3639-42. PubMed ID: 2817913
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pharmacotherapy of emesis caused by cytostatic agents].
    Baggerman C
    Ned Tijdschr Geneeskd; 1982 May; 126(18):803-7. PubMed ID: 6283396
    [No Abstract]   [Full Text] [Related]  

  • 17. [Domperidone as an anti-emetic in antineoplastic chemotherapy].
    Caruso U; D'Iddio S; Cravotto E; Pesce S; Betti I; Ruscitto G; Ecari U; Sabrie AM
    Minerva Chir; 1981 Jun; 36(11):787-91. PubMed ID: 7019761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of tropisetron and granisetron in the control of nausea and vomiting in children receiving combined cancer chemotherapy.
    Aksoylar S; Akman SA; Ozgenç F; Kansoy S
    Pediatr Hematol Oncol; 2001 Sep; 18(6):397-406. PubMed ID: 11554235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevention of cytostatic-induced vomiting. High-dosage metoclopramide versus an antiemetic combination in a controlled comparison].
    Ell C; König HJ; Gutmann W; Domschke S; Domschke W
    Med Welt; 1983 Sep; 34(35):945-8. PubMed ID: 6355746
    [No Abstract]   [Full Text] [Related]  

  • 20. Risk-benefit of antiemetics in prevention and treatment of chemotherapy-induced nausea and vomiting.
    Herrstedt J
    Expert Opin Drug Saf; 2004 May; 3(3):231-48. PubMed ID: 15155151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.